Caligiuri M - Search Results

1

A phase I trial of escalating doses of trastuzumab combined with daily subcutaneous interleukin 2: report of cancer and leukemia group B 9661.

Fleming GF, Meropol NJ, Rosner GL, Hollis DR, Carson WE 3rd, Caligiuri M, Mortimer J, Tkaczuk K, Parihar R, Schilsky RL, Ratain MJ. Fleming GF, et al. Among authors: caligiuri m. Clin Cancer Res. 2002 Dec;8(12):3718-27. Clin Cancer Res. 2002. PMID: 12473581 Clinical Trial.

2

The c-kit ligand suppresses apoptosis of human natural killer cells through the upregulation of bcl-2.

Carson WE, Haldar S, Baiocchi RA, Croce CM, Caligiuri MA. Carson WE, et al. Among authors: caligiuri ma. Proc Natl Acad Sci U S A. 1994 Aug 2;91(16):7553-7. doi: 10.1073/pnas.91.16.7553. Proc Natl Acad Sci U S A. 1994. PMID: 7519782 Free PMC article.

3

Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor.

Carson WE, Giri JG, Lindemann MJ, Linett ML, Ahdieh M, Paxton R, Anderson D, Eisenmann J, Grabstein K, Caligiuri MA. Carson WE, et al. Among authors: caligiuri ma. J Exp Med. 1994 Oct 1;180(4):1395-403. doi: 10.1084/jem.180.4.1395. J Exp Med. 1994. PMID: 7523571 Free PMC article.

4

The functional characterization of interleukin-10 receptor expression on human natural killer cells.

Carson WE, Lindemann MJ, Baiocchi R, Linett M, Tan JC, Chou CC, Narula S, Caligiuri MA. Carson WE, et al. Among authors: caligiuri ma. Blood. 1995 Jun 15;85(12):3577-85. Blood. 1995. PMID: 7540068 Free article.

5

Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-gamma by natural killer cells in vitro.

Carson WE, Ross ME, Baiocchi RA, Marien MJ, Boiani N, Grabstein K, Caligiuri MA. Carson WE, et al. Among authors: caligiuri ma. J Clin Invest. 1995 Dec;96(6):2578-82. doi: 10.1172/JCI118321. J Clin Invest. 1995. PMID: 8675621 Free PMC article.

6

Natural Killer Cell Subsets and Development.

Carson W, Caligiuri M. Carson W, et al. Among authors: caligiuri m. Methods. 1996 Apr;9(2):327-43. doi: 10.1006/meth.1996.0038. Methods. 1996. PMID: 8812686

7

Diabetes mellitus induced by low-dose interleukin-2.

Soni N, Meropol NJ, Porter M, Caligiuri MA. Soni N, et al. Among authors: caligiuri ma. Cancer Immunol Immunother. 1996 Sep;43(1):59-62. doi: 10.1007/s002620050304. Cancer Immunol Immunother. 1996. PMID: 8917637

8

Interleukin 15: a potential player during the innate immune response to infection.

Carson WE, Caligiuri MA. Carson WE, et al. Among authors: caligiuri ma. Exp Parasitol. 1996 Nov;84(2):291-4. doi: 10.1006/expr.1996.0115. Exp Parasitol. 1996. PMID: 8932779 Review. No abstract available.

9

CD56bright natural killer cell subsets: characterization of distinct functional responses to interleukin-2 and the c-kit ligand.

Carson WE, Fehniger TA, Caligiuri MA. Carson WE, et al. Among authors: caligiuri ma. Eur J Immunol. 1997 Feb;27(2):354-60. doi: 10.1002/eji.1830270203. Eur J Immunol. 1997. PMID: 9045904

10

A potential role for interleukin-15 in the regulation of human natural killer cell survival.

Carson WE, Fehniger TA, Haldar S, Eckhert K, Lindemann MJ, Lai CF, Croce CM, Baumann H, Caligiuri MA. Carson WE, et al. Among authors: caligiuri ma. J Clin Invest. 1997 Mar 1;99(5):937-43. doi: 10.1172/JCI119258. J Clin Invest. 1997. PMID: 9062351 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

676 results

Search Page

Filters